[Federal Register Volume 87, Number 120 (Thursday, June 23, 2022)]
[Pages 37520-37521]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-13419]



National Institutes of Health

Office of the Director, National Institutes of Health; Notice of 

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Novel and 
Exceptional Technology and Research Advisory Committee.
    The meeting will be held as a virtual meeting and is open to the 
public. Individuals who plan to view the virtual meeting and need 
special assistance or other reasonable accommodations to view the 
meeting should notify the Contact Person listed below in advance of the 
meeting. The meeting will be videocast and can be accessed from the NIH 
Videocasting and Podcasting website (http://videocast.nih.gov/).

    Name of Committee: Novel and Exceptional Technology and Research 
Advisory Committee.
    Date: July 14, 2022.
    Time: 1:00 p.m. to 2:30 p.m.
    Agenda: The Novel and Exceptional Technology and Research 
Advisory Committee meeting will include an update from the Working 
Group on Data Science and Emerging Technology and discussion of next 
steps regarding the current charge to the committee, delivered in 
June 2021.
    Place: National Institutes of Health, 6705 Rockledge Drive, 
Suite 630, Bethesda, MD 20892 (Virtual Meeting Link will be 
available at https://osp.od.nih.gov/biotechnology/main-nextrac/#meetings).
    Contact Person: Jessica Tucker, Office of Science Policy, 
National Institutes of Health, 6705 Rockledge Drive, Suite 630, 
Bethesda, MD 20892, 301-496-9838, [email protected].

    Any interested person may file written comments by forwarding 
the statement to the Contact Person listed on this notice at least 
two business days prior to the meeting date. The statement should 
include the name, address, telephone number and, when applicable, 
the business or professional affiliation of the interested person. 
Other than name and contact information, please do not include any 
personally identifiable information or any information that you do 
not wish to make public. Proprietary, classified, confidential, or 
sensitive information should not be included in your comments. 
Please note that any written comments NIH receives may be posted

[[Page 37521]]

unredacted to the Office of Science Policy website.
    Information is also available on the NIH Office of Science 
Policy website: https://osp.od.nih.gov/biotechnology/main-nextrac/#meetings, where an agenda, link to the webcast meeting, and any 
additional information for the meeting will be posted when 

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research Training Award; 93.22, Clinical Research Loan 
Repayment Program for Individuals from Disadvantaged Backgrounds; 
93.232, Loan Repayment Program for Research Generally; 93.39, 
Academic Research Enhancement Award; 93.936, NIH Acquired 
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, 
Undergraduate Scholarship Program for Individuals from Disadvantaged 
Backgrounds, National Institutes of Health, HHS)

    Dated: June 17, 2022.
Victoria Townsend,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-13419 Filed 6-22-22; 8:45 am]